Evaluation of E1A Double Mutant Oncolytic Adenovectors in Anti-Glioma Gene Therapy

Malignant glioma, in particular glioblastoma multiforme (GBM), represents one of the most devastating cancers currently known and existing treatment regimens do little to change patient prognosis. Conditionally replicating adenoviral vectors (CRAds) represent attractive experimental anti-cancer agen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ulasov, Ilya V., Tyler, Matthew A., Rivera, Angel A., Nettelbeck, Dirk M., Douglas, Joanne T., Lesniak, Maciej S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2365750/
https://ncbi.nlm.nih.gov/pubmed/18649343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.00000
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller